the data reported in this study give evidence that fce 22250 shows excellent in vitro results , even better than those obtained with rifampicin , leading to the possibility of clinical applications of this new drug on legionnaire 's disease and chlamydial infections .
C0035608
rifampicin
C0023241
legionnaire 's disease